Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: City of Hope Medical Center
Condition: Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma
NCT02744612
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.